ALDACTONE
What it isMineralocorticoid-receptor antagonist; heart failure, resistant hypertension, ascites, acne and hirsutism.
Why this oneUnlike eplerenone, its antiandrogen activity makes it useful for acne and hirsutism — and causes gynecomastia.
What limits itHyperkalemia and renal decline are limiting; check potassium and creatinine after initiation and dose changes.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Heart failure | Adults (K+ ≤5.0, eGFR >50) | 25 mg QD | 50 mg QD | |
| Essential hypertension | Adults | 25-100 mg/day (QD or divided) | 25-100 mg/day | 100 mg/day |
| Edema (incl. cirrhosis) | Adults | 100 mg/day (QD or divided; range 25-200) | 25-200 mg/day | |
| Primary hyperaldosteronism | Adults | 100-400 mg/day | lowest effective dose |
Titration HTN: titrate at 2-week intervals; edema (sole diuretic): wait ≥5 days before increasing.
Renal HF with eGFR 30-50 mL/min/1.73m²: consider 25 mg every other day (hyperkalemia risk).
Hepatic Cirrhosis/edema: initiate in hospital and titrate slowly; risk of impaired neurologic function/coma.
HF: reduce to 25 mg every other day if hyperkalemia develops.
Pregnancy Avoid; anti-androgenic activity may affect male fetal sex differentiation (animal data).
Lactation Metabolite canrenone present in milk in low, likely inconsequential amounts; weigh benefits/risks.
NO BOXED WARNINGS
Principal riskHyperkalemia
Cost, est. cash$4–$80/month
Generic entry1982
Legacy pregnancy categoryC
Defining liabilityHyperkalemia, kidney dysfunction and endocrine adverse effects.

Open Spironolactone in the interactive console ↗

